San Diego-based healthtech platform CIPRA.ai has launched its personalised services in India and a strategic partnership with renowned healthcare providers in the industry – RxDx and 2050 Healthcare and innovation partner ARTPARK @IISc Bengaluru, the company informed via a statement.
It said that the Bengaluru-based RxDx will help CIPRA.ai to expand its presence in India. ARTPARK @IISc Bangalore, AI and robotics accelerator backed by the Indian Institute of Science (IISc), is CIPRA.ai’s innovation partner.
The tie-up aims to help address gaps in conventional care and combat chronic diseases by providing data-based precision care in India. Through collective efforts, CIPRA.ai also aims to become a health tool that enables healthcare providers to lower the burden on clinician capacity in India.
Dr Sujit Dey, CEO and Founder, CIPRA.ai, stated in the statement, “At CIPRA.ai, we aim to improve personalised care delivery for patients as we understand that effective diagnosis and treatment for chronic conditions is not a one-size-fits-all solution. With the launch of our services in India, we aim to revolutionise how patients approach treatment. CIPRA.ai’s commercial partnership with RxDx and 2050 Healthcare and the support of ARTPARK @IISc Bengaluru will help us navigate this shift to deliver improved patient outcomes.”
